Literature DB >> 19376584

The Relationship between intraocular pressure and progressive retinal nerve fiber layer loss in glaucoma.

Felipe A Medeiros1, Luciana M Alencar, Linda M Zangwill, Pamela A Sample, Robert N Weinreb.   

Abstract

PURPOSE: To evaluate the relationship between intraocular pressure (IOP) and progressive retinal nerve fiber layer (RNFL) loss, as measured by scanning laser polarimetry with enhanced corneal compensation (GDx ECC), in a cohort of glaucoma patients and individuals suspected of having the disease followed over time.
DESIGN: Observational cohort study. PARTICIPANTS: The study included 344 eyes of 204 patients recruited from the Diagnostic Innovations in Glaucoma Study (DIGS). There were 98 eyes (28%) with a diagnosis of glaucoma and 246 (72%) were considered glaucoma suspects at baseline.
METHODS: Images were obtained annually with the GDx ECC scanning laser polarimeter, along with stereophotographs and SAP. The study included a total of 1211 GDx ECC visits with an average of 3.5 visits per eye. Progression was determined by the Guided Progression Analysis software for SAP and by masked assessment of stereophotographs performed by expert graders. MAIN OUTCOME MEASURES: Random coefficient models were used to evaluate the relationship between IOP and RNFL thickness measurements over time in progressors and nonprogressors. Models were adjusted for baseline diagnosis and central corneal thickness.
RESULTS: For all 344 eyes, the overall rate of change for the GDx ECC average thickness at an average IOP of 17 mmHg was -0.25 microm per year (P = 0.002). Each 1-mmHg higher IOP was associated with an additional loss of 0.05 microm per year of RNFL (P = 0.001). Twenty-nine eyes (8%) showed progression on SAP and/or optic disc stereophotographs. These eyes had a significantly higher rate of RNFL change (-0.95 microm/year) than nonprogressors (-0.17 microm/year; P = 0.001). For progressors, each 1-mmHg higher IOP was associated with an additional loss of 0.13 microm per year of RNFL.
CONCLUSIONS: Higher levels of IOP during follow-up were significantly related to higher rates of progressive RNFL loss detected by the GDx ECC. These findings suggest that the GDx ECC may be helpful in monitoring progression and estimating rates of change in patients with glaucoma or suspected of having the disease. Also, they may contribute to a better understanding of the relationship between IOP and structural deterioration in glaucoma. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Entities:  

Mesh:

Year:  2009        PMID: 19376584      PMCID: PMC2848169          DOI: 10.1016/j.ophtha.2008.12.062

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  34 in total

1.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  Individualized compensation of anterior segment birefringence during scanning laser polarimetry.

Authors:  Qienyuan Zhou; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

3.  Measurement of the magnitude and axis of corneal polarization with scanning laser polarimetry.

Authors:  Robert N Weinreb; Christopher Bowd; David S Greenfield; Linda M Zangwill
Journal:  Arch Ophthalmol       Date:  2002-07

4.  Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.

Authors:  P R Lichter; D C Musch; B W Gillespie; K E Guire; N K Janz; P A Wren; R P Mills
Journal:  Ophthalmology       Date:  2001-11       Impact factor: 12.079

5.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

6.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.

Authors:  M Roy Wilson; Omofolasade Kosoko; Claude L Cowan; Pamela A Sample; Chris A Johnson; Gleb Haynatzki; Cheryl Enger; David Crandall
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

8.  Measuring visual field progression in the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Boel Bengtsson; Bo Bengtsson; Mohamed Hussein
Journal:  Acta Ophthalmol Scand       Date:  2003-06

9.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Authors:  M Cristina Leske; Anders Heijl; Mohamed Hussein; Bo Bengtsson; Leslie Hyman; Eugene Komaroff
Journal:  Arch Ophthalmol       Date:  2003-01

10.  Detection of progressive retinal nerve fiber layer loss in glaucoma using scanning laser polarimetry with variable corneal compensation.

Authors:  Felipe A Medeiros; Luciana M Alencar; Linda M Zangwill; Christopher Bowd; Gianmarco Vizzeri; Pamela A Sample; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-21       Impact factor: 4.799

View more
  52 in total

1.  Improved prediction of rates of visual field loss in glaucoma using empirical Bayes estimates of slopes of change.

Authors:  Felipe A Medeiros; Linda M Zangwill; Robert N Weinreb
Journal:  J Glaucoma       Date:  2012-03       Impact factor: 2.503

2.  Combining structural and functional measurements to improve estimates of rates of glaucomatous progression.

Authors:  Felipe A Medeiros; Linda M Zangwill; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2012-02-07       Impact factor: 5.258

3.  The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change.

Authors:  Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Kaweh Mansouri; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

4.  What rates of glaucoma progression are clinically significant?

Authors:  Luke J Saunders; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Expert Rev Ophthalmol       Date:  2016-05-13

5.  Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma.

Authors:  Carolina P B Gracitelli; Ricardo Y Abe; Andrew J Tatham; Peter N Rosen; Linda M Zangwill; Erwin R Boer; Robert N Weinreb; Felipe A Medeiros
Journal:  JAMA Ophthalmol       Date:  2015-04       Impact factor: 7.389

Review 6.  Test-retest variability in structural parameters measured with glaucoma imaging devices.

Authors:  Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2012-11-09       Impact factor: 2.447

7.  Rates of Retinal Nerve Fiber Layer Loss in Contralateral Eyes of Glaucoma Patients with Unilateral Progression by Conventional Methods.

Authors:  Ting Liu; Andrew J Tatham; Carolina P B Gracitelli; Linda M Zangwill; Robert N Weinreb; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2015-09-15       Impact factor: 12.079

8.  The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.

Authors:  Linda M Zangwill; Sonia Jain; Keri Dirkes; Feng He; Felipe A Medeiros; Gary L Trick; James D Brandt; George A Cioffi; Anne L Coleman; Jeffrey M Liebmann; Jody R Piltz-Seymour; Mae O Gordon; Michael A Kass; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2013-03-14       Impact factor: 5.258

9.  Estimating the rate of retinal ganglion cell loss in glaucoma.

Authors:  Felipe A Medeiros; Linda M Zangwill; Douglas R Anderson; Jeffrey M Liebmann; Christopher A Girkin; Ronald S Harwerth; Marie-Josée Fredette; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2012-07-27       Impact factor: 5.258

10.  Retinal ganglion cell count estimates associated with early development of visual field defects in glaucoma.

Authors:  Felipe A Medeiros; Renato Lisboa; Robert N Weinreb; Jeffrey M Liebmann; Christopher Girkin; Linda M Zangwill
Journal:  Ophthalmology       Date:  2012-12-12       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.